3-氯奎宁环 盐酸盐 | 33601-77-3

• 物质功能分类: 有机原料 - 羧酸类化合物及衍生物
• 分子结构分类: 有机化合物 - 有机杂环化合物 - 奎宁环
• 中文名称: 3-氯奎宁环 盐酸盐
• 中文别名: 3-氯奎宁环盐酸盐
• 英文名称: 3-chloroquinuclidine hydrochloride
• 英文别名: 3-chloro-1-azoniabicyclo[2.2.2]octane;chloride
• CAS: 33601-77-3
• 化学式: C₇H₁₂ClN*ClH
• mdl: MFCD00012728
• 分子量: 182.093
• InChiKey: OOMINTVSHDCDRK-UHFFFAOYSA-N

物化性质

• 熔点：
  236-239 °C(lit.)
• 稳定性/保质期：
  如果遵照规格使用和储存，则不会分解，未有已知危险发生。应避免与强氧化剂接触。

计算性质

• 辛醇/水分配系数(LogP)：
  1.21
• 重原子数：
  10
• 可旋转键数：
  0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  3.2
• 氢给体数：
  1
• 氢受体数：
  1

安全信息

• 海关编码：
  2933990090
• WGK Germany：
  3

SDS

---

Section 1. IDENTIFICATION OF THE SUBSTANCE/MIXTURE
Product identifiers
Product name : 3-Chloroquinuclidine hydrochloride
CAS-No. : 33601-77-3
Relevant identified uses of the substance or mixture and uses advised against
Identified uses : Laboratory chemicals, Manufacture of substances

---

Section 2. HAZARDS IDENTIFICATION
Classification of the substance or mixture
Not a hazardous substance or mixture according to Regulation (EC) No. 1272/2008.
Not a hazardous substance or mixture according to EC-directives 67/548/EEC or 1999/45/EC.
Label elements
The product does not need to be labelled in accordance with EC directives or respective national laws.
Other hazards - none

---

Section 3. COMPOSITION/INFORMATION ON INGREDIENTS
Substances
Formula : C7H12ClN · HCl
Molecular Weight : 182,09 g/mol

---

Section 4. FIRST AID MEASURES
Description of first aid measures
If inhaled
If breathed in, move person into fresh air. If not breathing, give artificial respiration.
In case of skin contact
Wash off with soap and plenty of water.
In case of eye contact
Flush eyes with water as a precaution.
If swallowed
Never give anything by mouth to an unconscious person. Rinse mouth with water.
Most important symptoms and effects, both acute and delayed
To the best of our knowledge, the chemical, physical, and toxicological properties have not been
thoroughly investigated.
Indication of any immediate medical attention and special treatment needed
no data available

---

Section 5. FIREFIGHTING MEASURES
Extinguishing media
Suitable extinguishing media
Use water spray, alcohol-resistant foam, dry chemical or carbon dioxide.
Special hazards arising from the substance or mixture
Carbon oxides, nitrogen oxides (NOx), Hydrogen chloride gas
Advice for firefighters
Wear self contained breathing apparatus for fire fighting if necessary.
Further information
no data available

---

Section 6. ACCIDENTAL RELEASE MEASURES
Personal precautions, protective equipment and emergency procedures
Avoid dust formation. Avoid breathing vapors, mist or gas.
Environmental precautions
Do not let product enter drains.
Methods and materials for containment and cleaning up
Sweep up and shovel. Keep in suitable, closed containers for disposal.
Reference to other sections
For disposal see section 13.

---

Section 7. HANDLING AND STORAGE
Precautions for safe handling
Provide appropriate exhaust ventilation at places where dust is formed.Normal measures for preventive fire
protection.
Conditions for safe storage, including any incompatibilities
Store in cool place. Keep container tightly closed in a dry and well-ventilated place.
Specific end uses
no data available

---

Section 8. EXPOSURE CONTROLS/PERSONAL PROTECTION
Control parameters
Components with workplace control parameters
Exposure controls
Appropriate engineering controls
General industrial hygiene practice.
Personal protective equipment
Eye/face protection
Use equipment for eye protection tested and approved under appropriate government standards
such as NIOSH (US) or EN 166(EU).
Skin protection
Handle with gloves. Gloves must be inspected prior to use. Use proper glove removal technique
(without touching glove's outer surface) to avoid skin contact with this product. Dispose of
contaminated gloves after use in accordance with applicable laws and good laboratory practices.
Wash and dry hands.
The selected protective gloves have to satisfy the specifications of EU Directive 89/686/EEC and
the standard EN 374 derived from it.
Body Protection
Choose body protection in relation to its type, to the concentration and amount of dangerous
substances, and to the specific work-place., The type of protective equipment must be selected
according to the concentration and amount of the dangerous substance at the specific workplace.
Respiratory protection
Respiratory protection is not required. Where protection from nuisance levels of dusts are desired,
use type N95 (US) or type P1 (EN 143) dust masks. Use respirators and components tested and
approved under appropriate government standards such as NIOSH (US) or CEN (EU).

---

Section 9. PHYSICAL AND CHEMICAL PROPERTIES
Information on basic physical and chemical properties
a) Appearance Form: powder
Colour: tan
b) Odour no data available
c) Odour Threshold no data available
d) pH no data available
e) Melting point/freezing Melting point/range: 236 - 239 °C - lit.
point
f) Initial boiling point and no data available
boiling range
g) Flash point no data available
h) Evaporation rate no data available
i) Flammability (solid, gas) no data available
j) Upper/lower no data available
flammability or
explosive limits
k) Vapour pressure no data available
l) Vapour density no data available
m) Relative density no data available
n) Water solubility no data available
o) Partition coefficient: n- no data available
octanol/water
p) Autoignition no data available
temperature
q) Decomposition no data available
temperature
r) Viscosity no data available
s) Explosive properties no data available
t) Oxidizing properties no data available
Other safety information
no data available

---

Section 10. STABILITY AND REACTIVITY
Reactivity
no data available
Chemical stability
no data available
Possibility of hazardous reactions
no data available
Conditions to avoid
no data available
Incompatible materials
Strong oxidizing agents
Hazardous decomposition products
Other decomposition products - no data available

---

Section 11. TOXICOLOGICAL INFORMATION
Information on toxicological effects
Acute toxicity
no data available
Skin corrosion/irritation
no data available
Serious eye damage/eye irritation
no data available
Respiratory or skin sensitization
no data available
Germ cell mutagenicity
no data available
Carcinogenicity
IARC: No component of this product present at levels greater than or equal to 0.1% is identified as
probable, possible or confirmed human carcinogen by IARC.
Reproductive toxicity
no data available
Specific target organ toxicity - single exposure
no data available
Specific target organ toxicity - repeated exposure
no data available
Aspiration hazard
no data available
Potential health effects
Inhalation
May be harmful if inhaled. May cause respiratory tract irritation.
Ingestion May be harmful if swallowed.
Skin May be harmful if absorbed through skin. May cause skin irritation.
Eyes May cause eye irritation.
Signs and Symptoms of Exposure
To the best of our knowledge, the chemical, physical, and toxicological properties have not been
thoroughly investigated.
Additional Information
RTECS: Not available

---

Section 12. ECOLOGICAL INFORMATION
Toxicity
no data available
Persistence and degradability
no data available
Bioaccumulative potential
no data available
Mobility in soil
no data available
Results of PBT and vPvB assessment
no data available
Other adverse effects
no data available

---

Section 13. DISPOSAL CONSIDERATIONS
Waste treatment methods
Product
Offer surplus and non-recyclable solutions to a licensed disposal company.
Contaminated packaging
Dispose of as unused product.

---

Section 14. TRANSPORT INFORMATION
UN number
ADR/RID: - IMDG: - IATA: -
UN proper shipping name
ADR/RID: Not dangerous goods
IMDG: Not dangerous goods
IATA: Not dangerous goods
Transport hazard class(es)
ADR/RID: - IMDG: - IATA: -
Packaging group
ADR/RID: - IMDG: - IATA: -
Environmental hazards
ADR/RID: no IMDG Marine pollutant: no IATA: no
Special precautions for user
no data available

---

Section 15. REGULATORY INFORMATION
This safety datasheet complies with the requirements of Regulation (EC) No. 1907/2006.
Safety, health and environmental regulations/legislation specific for the substance or mixture
no data available
Chemical Safety Assessment
no data available

---

Section 16. OTHER INFORMATION
Further information
Copyright 2012 Co. LLC. License granted to make unlimited paper copies for internal use
only.
The above information is believed to be correct but does not purport to be all inclusive and shall be
used only as a guide. The information in this document is based on the present state of our knowledge
and is applicable to the product with regard to appropriate safety precautions. It does not represent any
guarantee of the properties of the product. Corporation and its Affiliates shall not be held
liable for any damage resulting from handling or from contact with the above product. See
and/or the reverse side of invoice or packing slip for additional terms and conditions of sale.

反应信息

• 作为反应物：
  描述：

  3-氯奎宁环 盐酸盐 在 甲醇 、 sodium methylate 、 镍 作用下， 60.0 ℃ 、9.81 MPa 条件下， 生成 奎宁环
  参考文献：
  名称：

  2-脱氢喹啉和一些3-取代产物。奎尼丁系列的研究。第五次沟通

  摘要：

  已经制备了脱氢喹核苷（Ia）和几种3-取代的衍生物，并将其还原为相应的喹核苷。

  DOI：

  10.1002/hlca.19570400717
• 作为产物：
  描述：

  3-奎宁环酮盐酸盐 在 sodium hydroxide 、 氯化亚砜 、 水 、 镍 作用下， 生成 3-氯奎宁环 盐酸盐
  参考文献：
  名称：

  2-脱氢喹啉和一些3-取代产物。奎尼丁系列的研究。第五次沟通

  摘要：

  已经制备了脱氢喹核苷（Ia）和几种3-取代的衍生物，并将其还原为相应的喹核苷。

  DOI：

  10.1002/hlca.19570400717

文献信息

• Synthesis and Activity of a Novel Series of 3-Biarylquinuclidine Squalene Synthase Inhibitors
  作者：George R. Brown、David S. Clarke、Alan J. Foubister、Susan Freeman、Peter J. Harrison、Michael C. Johnson、Keith B. Mallion、John McCormick、Fergus McTaggart、Alan C. Reid、Graham J. Smith、Melvyn J. Taylor

  DOI：10.1021/jm950907l

  日期：1996.1.1

  Quinuclidines with a 3-biaryl substituent are a new class of potent, orally active squalene synthase (SQS) inhibitors. Variants around these rigid structures indicate key structural requirements for cationic SQS inhibitors. Thus the lower in vitro potency found for quinuclidines bearing 3-substituents, which did not overlay the biphenyl group of 3-(biphenyl-4-yl)-3-hydroxyquinuclidine (2) (IC50 = 16

  具有3-联芳基取代基的喹核苷是一类新的有效的，口服活性的角鲨烯合酶（SQS）抑制剂。这些刚性结构周围的变化指示出阳离子SQS抑制剂的关键结构要求。因此，暗示了带有3个取代基的喹核苷的体外效价较低，该奎尼啶没有覆盖3-（联苯基-4-基）-3-羟基喹核苷（2）的联苯基团（IC50 = 16 nM，大鼠微粒体SQS）。 3取代基的方向性要求。类似地，3-三联苯类似物6的较低效能（IC50 = 370 nM）表明该取代基的尺寸受到限制。在具有奎宁环和联苯环之间连接基团的化合物中，亲脂性较低的连接基团的耐受性较差（例如，17，CH2CH2，IC50 = 5 nM与19，NHCO，IC50 = 1.2 microM）。用更具极性的吡啶杂环取代2的远端苯环会导致体外效能降低。通常，大鼠体内的良好体内活性仅限于3-羟基类似物，其中3- [4-（吡啶-4-基）苯基]衍生物39（IC50 = 161 nM）显示出最佳的抑制作用（口服给药后）
• SUBSTITUTED 1-AMINOPHTHALAZINE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC APPLICATION THEREOF
  申请人：AUGEREAU Jean Michel

  公开号：US20090124624A1

  公开（公告）日：2009-05-14

  The invention concerns 1-amino-phthalazine derivatives of general formula (I): Wherein A, B, L, R, R 1 , R 2 , R 3 , R 4 , R 5 and R 7 are as defined herein. The invention also concerns the preparation of said compounds and their therapeutic use.

  这项发明涉及一般式(I)的1-氨基邻苯二酮衍生物：其中A、B、L、R、R1、R2、R3、R4、R5和R7如本文所定义。该发明还涉及所述化合物的制备及其治疗用途。
• 3-Quinuclidinyl heteroatom bridged biaryl derivatives
  申请人：Ji Jianguo

  公开号：US20050137226A1

  公开（公告）日：2005-06-23

  Compounds of formula: or pharmaceutically acceptable salts, esters, amides, or prodrugs thereof, wherein: A and G are each independently N or N + —O − ; m and n are each independently 0, 1, or 2; X 1 and X 3 are each independently O, S, and —N(R 1 )—; X 2 is O, S, —N(R 1 )—, —N(Ar 2 )—, and —N(R 2 )C(O)—; Ar 1 is a six-membered aromatic ring; Ar 2 is cyclohexyl or a mono- or bicyclic aromatic ring, and R 13 is hydrogen, alkyl, or halogen, as defined herein. The compounds are useful in treating conditions or disorders prevented by or ameliorated by nAChR ligands. Also disclosed are pharmaceutical compositions having compounds of formulas (I) and (II) and methods for using such compounds and compositions.

  化合物的化学式：或其药学上可接受的盐、酯、酰胺或前药，其中：A和G分别独立为N或N+—O−；m和n分别独立为0、1或2；X1和X3分别独立为O、S和—N(R1)—；X2为O、S、—N(R1)—、—N(Ar2)—和—N(R2)C(O)—；Ar1是一个六元芳香环；Ar2是环己烷或单环或双环芳香环，R13是氢、烷基或卤素，如本文所定义。这些化合物可用于治疗由nAChR配体预防或改善的病症或障碍。还公开了含有化合物的药物组合物的化学式(I)和(II)以及使用这些化合物和组合物的方法。
• Quaternary salts derived from 3-substituted quinuclidine as potential antioxidative and antimicrobial agents
  作者：Renata Odžak、Matilda Šprung、Barbara Soldo、Mirjana Skočibušić、Martina Gudelj、Anita Muić、Ines Primožič

  DOI：10.1515/chem-2017-0031

  日期：2017.12.19

  Abstract Two series of novel ammonium salts containing the quinuclidine moiety were prepared in order to evaluate their antioxidative, antibacterial and antifungal potential. The synthesized homologues of 3-hydroxy (QOH) and 3-chloroquinuclidine (QCl) with the different N-benzyl substituents at the para-position (bromo, chloro or nitro group) were obtained in very good yields and characterized by IR

  摘要 为了评价其抗氧化、抗菌和抗真菌潜力，制备了两个系列含有奎宁环部分的新型铵盐。合成的 3-羟基 (QOH) 和 3-氯奎宁环 (QCl) 的同系物在对位（溴、氯或硝基）具有不同的 N-苄基取代基，收率非常好，并通过 IR 和 NMR 光谱表征和元素分析。使用氧自由基吸收能力 (ORAC) 测定法测试了所有化合物的抗氧化活性，在测试样品中，Np-硝基苄基-3-羟基奎宁环溴化物 (QOH-4) 表现出最高的抗氧化潜力 (293.80 nmol (TE) mL-1) ，这通过 DNA 切口测定进一步研究。通过测量抑菌圈和测定对三种革兰氏阳性菌（蜡状芽孢杆菌、粪肠球菌和金黄色葡萄球菌）、三种革兰氏阴性菌（ E. coli、P. aeruginosa 和 C. sakazakii）和三种真菌（C. albicans、A. niger 和 P. notatum）。生物活性测定表明，一些新合成的季铵盐化合物显示出与庆大霉素
• (METH)ACRYLATE MANUFACTURING METHOD
  申请人：TOAGOSEI CO., LTD

  公开号：US20180118658A1

  公开（公告）日：2018-05-03

  The present invention provides a (meth)acrylate manufacturing method characterized in that when manufacturing a (meth) acrylate by an ester exchange reaction between an alcohol and a monofunctional (meth)acrylate using catalyst A and catalyst B together, contact treatment of the ester exchange reaction product with adsorbent C is performed. Catalyst A: One or more kinds of compounds selected from a group consisting of cyclic tertiary amines with an azabicyclo structure and salts or complexes thereof, amidine and salts or complexes thereof, compounds with a pyridine ring and salts or complexes thereof, phosphines and salts or complexes thereof, and compounds with a tertiary diamine structure and salts or complexes thereof. Catalyst B: One or more kinds of compounds selected from a group consisting of compounds comprising zinc. Adsorbent C: One or more kinds of compounds selected from a group consisting of oxides and hydroxides comprising at least one of magnesium, aluminum and silicon.

  本发明提供了一种（甲基）丙烯酸酯制备方法，其特征在于通过在使用催化剂A和催化剂B一起进行醇和单官能基（甲基）丙烯酸酯之间的酯交换反应制备（甲基）丙烯酸酯时，对酯交换反应产物进行与吸附剂C的接触处理。催化剂A：从含有氮杂双环结构的环状三级胺及其盐或络合物、胺嘧啶及其盐或络合物、含有吡啶环的化合物及其盐或络合物、膦及其盐或络合物、以及含有三级二胺结构的化合物及其盐或络合物中选择的一种或多种化合物。催化剂B：从含锌化合物中选择的一种或多种化合物。吸附剂C：从含有镁、铝和硅中至少一种的氧化物和氢氧化物中选择的一种或多种化合物。

表征谱图